{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:55:39Z","timestamp":1790952939764,"version":"4.1.0"},"reference-count":48,"publisher":"Pleiades Publishing Ltd","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1134\/s0006297926601954","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:02Z","timestamp":1790951462000},"page":"1644-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction of the Full-Length FoxP3 Splice Variant during ex\u00a0vivo Transformation of\u00a0Human CD4+\u00a0T\u00a0Lymphocytes into Regulatory T\u00a0Cells"],"prefix":"10.1134","volume":"91","author":[{"given":"Varvara G.","family":"Blinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia A.","family":"Gladilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya N.","family":"Shishparenok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria D.","family":"Eliseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry D.","family":"Zhdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"3093_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S. Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155, 1151-1164, \nhttps:\/\/doi.org\/10.4049\/jimmunol.155.3.1151.","journal-title":"J. Immunol."},{"key":"3093_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.0105-2896.2006.00417.x","volume":"212","author":"C. Baecher-Allan","year":"2006","unstructured":"Baecher-Allan, C., and Hafler, D. A. (2006) Human regulatory T cells and their role in autoimmune disease, Immunol. Rev., 212, 203-216, \nhttps:\/\/doi.org\/10.1111\/j.0105-2896.2006.00417.x.","journal-title":"Immunol. Rev."},{"key":"3093_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1101-0","volume":"15","author":"A. Vallarola","year":"2018","unstructured":"Vallarola, A., Sironi, F., Tortarolo, M., Gatto, N., De Gioia, R., Pasetto, L., De Paola, M., Mariani, A., Ghosh, S., Watson, R., Kalmes, A., Bonetto, V., and Bendotti, C. (2018) RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue, J. Neuroinflammation, 15, 65, \nhttps:\/\/doi.org\/10.1186\/s12974-018-1101-0.","journal-title":"J. Neuroinflammation"},{"key":"3093_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1056\/NEJMcibr2033544","volume":"384","author":"J. M. Goverman","year":"2021","unstructured":"Goverman, J. M. (2021) Regulatory T cells in multiple sclerosis, N. Engl. J. Med., 384, 578-580, \nhttps:\/\/doi.org\/10.1056\/NEJMcibr2033544.","journal-title":"N. Engl. J. Med."},{"key":"3093_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/21678421.2020.1752246","volume":"21","author":"I. Giovannelli","year":"2020","unstructured":"Giovannelli, I., Heath, P., Shaw, P. J., and Kirby, J. (2020) The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential, Amyotroph. Lateral Scler. Frontotemporal Degener., 21, 435-444, \nhttps:\/\/doi.org\/10.1080\/21678421.2020.1752246.","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"3093_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101359","volume":"12","author":"V. G. Blinova","year":"2023","unstructured":"Blinova, V. G., Vasilyev, V. I., Rodionova, E. B., and Zhdanov, D. D. (2023) The role of regulatory T cells in the onset and progression of primary Sj\u00f6gren's syndrome, Cells, 12, 1359, \nhttps:\/\/doi.org\/10.3390\/cells12101359.","journal-title":"Cells"},{"key":"3093_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S. Hori","year":"2003","unstructured":"Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057-1061, \nhttps:\/\/doi.org\/10.1126\/science.1079490.","journal-title":"Science"},{"key":"3093_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"A. Y. Rudensky","year":"2011","unstructured":"Rudensky, A. Y. (2011) Regulatory T cells and Foxp3, Immunol. Rev., 241, 260-268, \nhttps:\/\/doi.org\/10.1111\/j.1600-065X.2011.01018.x.","journal-title":"Immunol. Rev."},{"key":"3093_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010077","volume":"13","author":"V. G. Blinova","year":"2023","unstructured":"Blinova, V. G., Gladilina, Y. A., Abramova, A. A., Eliseeva, D. D., Vtorushina, V. V., Shishparenok, A. N., and Zhdanov, D. D. (2023) Modulation of suppressive activity and proliferation of human regulatory T cells by splice-switching oligonucleotides targeting FoxP3 pre-mRNA, Cells, 13, 77, \nhttps:\/\/doi.org\/10.3390\/cells13010077.","journal-title":"Cells"},{"key":"3093_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12051022","volume":"12","author":"D. D. Zhdanov","year":"2024","unstructured":"Zhdanov, D. D., Gladilina, Y. A., Blinova, V. G., Abramova, A. A., Shishparenok, A. N., and Eliseeva, D. D. (2024) Induction of FoxP3 pre-mRNA alternative splicing to enhance the suppressive activity of regulatory T cells from amyotrophic lateral sclerosis patients, Biomedicines, 12, 1022, \nhttps:\/\/doi.org\/10.3390\/biomedicines12051022.","journal-title":"Biomedicines"},{"key":"3093_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","volume":"142","author":"J. H. Esensten","year":"2018","unstructured":"Esensten, J. H., Muller, Y. D., Bluestone, J. A., and Tang, Q. (2018) Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier, J. Allergy Clin. Immunol., 142, 1710-1718, \nhttps:\/\/doi.org\/10.1016\/j.jaci.2018.10.015.","journal-title":"J. Allergy Clin. Immunol."},{"key":"3093_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197015","volume":"21","author":"P. J. Eggenhuizen","year":"2020","unstructured":"Eggenhuizen, P. J., Ng, B. H., and Ooi, J. D. (2020) Treg enhancing therapies to treat autoimmune diseases, Int. J. Mol. Sci., 21, 7015, \nhttps:\/\/doi.org\/10.3390\/ijms21197015.","journal-title":"Int. J. Mol. Sci."},{"key":"3093_CR13","first-page":"73","volume":"22","author":"B. Arellano","year":"2016","unstructured":"Arellano, B., Graber, D. J., and Sentman, C. L. (2016) Regulatory T cell-based therapies for autoimmunity, Discov. Med., 22, 73-80.","journal-title":"Discov. Med."},{"key":"3093_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/cei.13297","volume":"197","author":"K. N. MacDonald","year":"2019","unstructured":"MacDonald, K. N., Piret, J. M., and Levings, M. K. (2019) Methods to manufacture regulatory T cells for cell therapy, Clin. Exp. Immunol., 197, 52-63, \nhttps:\/\/doi.org\/10.1111\/cei.13297.","journal-title":"Clin. Exp. Immunol."},{"key":"3093_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/08916934.2016.1199020","volume":"49","author":"G. V. Lifshitz","year":"2016","unstructured":"Lifshitz, G. V., Zhdanov, D. D., Lokhonina, A. V., Eliseeva, D. D., Lyssuck, E. Y., Zavalishin, I. A., and Bykovskaia, S. N. (2016) Ex vivo expanded regulatory T cells CD4+CD25+FoxP3+CD127Low develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis, Autoimmunity, 49, 388-396, \nhttps:\/\/doi.org\/10.1080\/08916934.2016.1199020.","journal-title":"Autoimmunity"},{"key":"3093_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/app11135776","volume":"11","author":"V. G. Blinova","year":"2021","unstructured":"Blinova, V. G., Novachly, N. S., Gippius, S. N., Hilal, A., Gladilina, Y. A., Eliseeva, D. D., and Zhdanov, D. D. (2021) Phenotypical and functional characteristics of human regulatory T cells during ex vivo maturation from CD4+ T lymphocytes, Appl. Sci., 11, 5776, \nhttps:\/\/doi.org\/10.3390\/app11135776.","journal-title":"Appl. Sci."},{"key":"3093_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2184.1995.tb00062.x","volume":"28","author":"J. L. Sherley","year":"1995","unstructured":"Sherley, J. L., Stadler, P. B., and Stadler, J. S. (1995) A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells, Cell Prolif., 28, 137-144, \nhttps:\/\/doi.org\/10.1111\/j.1365-2184.1995.tb00062.x.","journal-title":"Cell Prolif."},{"key":"3093_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbrc.2018.12.186","volume":"509","author":"D. D. Zhdanov","year":"2019","unstructured":"Zhdanov, D. D., Plyasova, A. A., Gladilina, Y. A., Pokrovsky, V. S., Grishin, D. V., Grachev, V. A., Orlova, V. S., Pokrovskaya, M. V., Alexandrova, S. S., Lobaeva, T. A., and Sokolov, N. N. (2019) Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4+ T lymphocytes, Biochem. Biophys. Res. Commun., 509, 789-796, \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2018.12.186.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3093_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1134\/S0006297917080041","volume":"82","author":"D. D. Zhdanov","year":"2017","unstructured":"Zhdanov, D. D., Pokrovsky, V. S., Orlova, E. V., Orlova, V. S., Pokrovskaya, M. V., Aleksandrova, S. S., and Sokolov, N. N. (2017) Intracellular localization of apoptotic endonuclease EndoG and splice-variants of telomerase catalytic subunit hTERT, Biochemistry (Moscow), 82, 894-905, \nhttps:\/\/doi.org\/10.1134\/S0006297917080041.","journal-title":"Biochemistry (Moscow)"},{"key":"3093_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.26502\/ami.93650036","volume":"3","author":"E. Claeys","year":"2019","unstructured":"Claeys, E., and Vermeire, K. (2019) The CD4 receptor: an indispensable protein in T cell activation and a promising target for immunosuppression, Arch. Microbiol. Immunol., 3, 133-150, \nhttps:\/\/doi.org\/10.26502\/ami.93650036.","journal-title":"Arch. Microbiol. Immunol."},{"key":"3093_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007980","volume":"4","author":"T. M. Brusko","year":"2009","unstructured":"Brusko, T. M., Wasserfall, C. H., Hulme, M. A., Cabrera, R., Schatz, D., and Atkinson, M. A. (2009) Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation, PLoS One, 4, e7980, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0007980.","journal-title":"PLoS One"},{"key":"3093_CR22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"W. Liu","year":"2006","unstructured":"Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., Clayberger, C., Soper, D. M., Ziegler, S. F., and Bluestone, J. A. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J. Exp. Med., 203, 1701-1711, \nhttps:\/\/doi.org\/10.1084\/jem.20060772.","journal-title":"J. Exp. Med."},{"key":"3093_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5574472","volume":"2021","author":"W.-Q. Yu","year":"2021","unstructured":"Yu, W.-Q., Ji, N.-F., Gu, C.-J., Wang, Y.-L., Huang, M., and Zhang, M.-S. (2021) Coexpression of Helios in Foxp3+ regulatory T cells and its role in human disease, Dis. Markers, 2021, 5574472, \nhttps:\/\/doi.org\/10.1155\/2021\/5574472.","journal-title":"Dis. Markers"},{"key":"3093_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00315","volume":"7","author":"M. Klein","year":"2016","unstructured":"Klein, M., and Bopp, T. (2016) Cyclic AMP represents a crucial component of Treg cell-mediated immune regulation, Front. Immunol., 7, 315, \nhttps:\/\/doi.org\/10.3389\/fimmu.2016.00315.","journal-title":"Front. Immunol."},{"key":"3093_CR25","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.4049\/jimmunol.180.9.5916","volume":"180","author":"B. Liang","year":"2008","unstructured":"Liang, B., Workman, C., Lee, J., Chew, C., Dale, B. M., Colonna, L., Flores, M., Li, N., Schweighoffer, E., Greenberg, S., Tybulewicz, V., Vignali, D., and Clynes, R. (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II, J. Immunol., 180, 5916-5926, \nhttps:\/\/doi.org\/10.4049\/jimmunol.180.9.5916.","journal-title":"J. Immunol."},{"key":"3093_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00051","volume":"3","author":"A. Schmidt","year":"2012","unstructured":"Schmidt, A., Oberle, N., and Krammer, P. H. (2012) Molecular mechanisms of Treg-mediated T cell suppression, Front. Immunol., 3, 51, \nhttps:\/\/doi.org\/10.3389\/fimmu.2012.00051.","journal-title":"Front. Immunol."},{"key":"3093_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cellimm.2018.06.008","volume":"331","author":"D. D. Zhdanov","year":"2018","unstructured":"Zhdanov, D. D., Gladilina, Y. A., Pokrovsky, V. S., Grishin, D. V., Grachev, V. A., Orlova, V. S., Pokrovskaya, M. V., Alexandrova, S. S., and Sokolov, N. N. (2018) Murine regulatory T cells induce death of effector T, B, and NK lymphocytes through a contact-independent mechanism involving telomerase suppression and telomere-associated senescence, Cell. Immunol., 331, 146-160, \nhttps:\/\/doi.org\/10.1016\/j.cellimm.2018.06.008.","journal-title":"Cell. Immunol."},{"key":"3093_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.molimm.2018.07.017","volume":"101","author":"D. D. Zhdanov","year":"2018","unstructured":"Zhdanov, D. D., Gladilina, Y. A., Grishin, D. V., Grachev, V. A., Orlova, V. S., Pokrovskaya, M. V., Alexandrova, S. S., Pokrovsky, V. S., and Sokolov, N. N. (2018) Contact-independent suppressive activity of regulatory T cells is associated with telomerase inhibition, telomere shortening and target lymphocyte apoptosis, Mol. Immunol., 101, 229-244, \nhttps:\/\/doi.org\/10.1016\/j.molimm.2018.07.017.","journal-title":"Mol. Immunol."},{"key":"3093_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1756-185X.13962","volume":"24","author":"D. Wang","year":"2021","unstructured":"Wang, D., and Lei, L. (2021) Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases, Int. J. Rheum. Dis., 24, 21-27, \nhttps:\/\/doi.org\/10.1111\/1756-185X.13962.","journal-title":"Int. J. Rheum. Dis."},{"key":"3093_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00129","volume":"4","author":"T. H. S. Ng","year":"2013","unstructured":"Ng, T. H. S., Britton, G. J., Hill, E. V., Verhagen, J., Burton, B. R., and Wraith, D. C. (2013) Regulation of adaptive immunity: the role of interleukin-10, Front. Immunol., 4, 129, \nhttps:\/\/doi.org\/10.3389\/fimmu.2013.00129.","journal-title":"Front. Immunol."},{"key":"3093_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102376","volume":"110","author":"C. Scheinecker","year":"2020","unstructured":"Scheinecker, C., G\u00f6schl, L., and Bonelli, M. (2020) Treg cells in health and autoimmune diseases: new insights from single cell analysis, J. Autoimmun., 110, 102376, \nhttps:\/\/doi.org\/10.1016\/j.jaut.2019.102376.","journal-title":"J. Autoimmun."},{"key":"3093_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100130","volume":"4","author":"A. Rajendeeran","year":"2021","unstructured":"Rajendeeran, A., and Tenbrock, K. (2021) Regulatory T cell function in autoimmune disease, J. Transl. Autoimmun., 4, 100130, \nhttps:\/\/doi.org\/10.1016\/j.jtauto.2021.100130.","journal-title":"J. Transl. Autoimmun."},{"key":"3093_CR33","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1111\/jcmm.15743","volume":"24","author":"L. Yang","year":"2020","unstructured":"Yang, L., Wang, G., and Xia, H. (2020) Molecular mechanism for impaired suppressive function of Tregs in autoimmune diseases: a summary of cell-intrinsic and cell-extrinsic factors, J. Cell. Mol. Med., 24, 11056-11063, \nhttps:\/\/doi.org\/10.1111\/jcmm.15743.","journal-title":"J. Cell. Mol. Med."},{"key":"3093_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932485","volume":"13","author":"K. J. Bednar","year":"2022","unstructured":"Bednar, K. J., Lee, J. H., and Ort, T. (2022) Tregs in autoimmunity: insights into intrinsic brake mechanism driving pathogenesis and immune homeostasis, Front. Immunol., 13, 932485, \nhttps:\/\/doi.org\/10.3389\/fimmu.2022.932485.","journal-title":"Front. Immunol."},{"key":"3093_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114624","volume":"155","author":"M. Hassan","year":"2025","unstructured":"Hassan, M., Elzallat, M., Mohammed, D. M., Balata, M., and El-Maadawy, W. H. (2025) Exploiting regulatory T cells (Tregs): cutting-edge therapy for autoimmune diseases, Int. Immunopharmacol., 155, 114624, \nhttps:\/\/doi.org\/10.1016\/j.intimp.2025.114624.","journal-title":"Int. Immunopharmacol."},{"key":"3093_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1511671","volume":"16","author":"M. S. Fisher","year":"2025","unstructured":"Fisher, M. S., and Sennikov, S. V. (2025) T-regulatory cells for the treatment of autoimmune diseases, Front. Immunol., 16, 1511671, \nhttps:\/\/doi.org\/10.3389\/fimmu.2025.1511671.","journal-title":"Front. Immunol."},{"key":"3093_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2023.100074","volume":"5","author":"N. Heldager Pedersen","year":"2024","unstructured":"Heldager Pedersen, N., Bjerregaard Jeppesen, H., Persson, G., Bojesen, S., and Hviid, T. V. F. (2024) An increase in regulatory T cells in peripheral blood correlates with an adverse prognosis for malignant melanoma patients \u2014 a study of T cells and natural killer cells, Curr. Res. Immunol., 5, 100074, \nhttps:\/\/doi.org\/10.1016\/j.crimmu.2023.100074.","journal-title":"Curr. Res. Immunol."},{"key":"3093_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350506","volume":"54","author":"C. Menier","year":"2024","unstructured":"Menier, C., Meunier, S., Porcheddu, V., Romano, L., Correia, E., Busato, F., Tost, J., and Maill\u00e8re, B. (2024) Frequency of natural regulatory T cells specific for factor VIII in the peripheral blood of healthy donors, Eur. J. Immunol., 54, e2350506, \nhttps:\/\/doi.org\/10.1002\/eji.202350506.","journal-title":"Eur. J. Immunol."},{"key":"3093_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"J. D. Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol., 4, 330-336, \nhttps:\/\/doi.org\/10.1038\/ni904.","journal-title":"Nat. Immunol."},{"key":"3093_CR40","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.37959","volume":"65","author":"M. E. Free","year":"2013","unstructured":"Free, M. E., Bunch, D. O., McGregor, J. A., Jones, B. E., Berg, E. A., Hogan, S. L., Hu, Y., Preston, G. A., Jennette, J. C., Falk, R. J., and Su, M. A. (2013) Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population, Arthritis Rheum., 65, 1922-1933, \nhttps:\/\/doi.org\/10.1002\/art.37959.","journal-title":"Arthritis Rheum."},{"key":"3093_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","volume":"76","author":"C. Miyabe","year":"2017","unstructured":"Miyabe, C., Miyabe, Y., Strle, K., Kim, N. D., Stone, J. H., Luster, A. D., and Unizony, S. (2017) An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy, Ann. Rheum. Dis., 76, 898-905, \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-210070.","journal-title":"Ann. Rheum. Dis."},{"key":"3093_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102069","volume":"85","author":"M. N. Alhosseini","year":"2024","unstructured":"Alhosseini, M. N., Ebadi, P., Karimi, M. H., Migliorati, G., Cari, L., Nocentini, G., Heidari, M., and Soleimanian, S. (2024) Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: a review of the strengths and limitations, Transpl. Immunol., 85, 102069, \nhttps:\/\/doi.org\/10.1016\/j.trim.2024.102069.","journal-title":"Transpl. Immunol."},{"key":"3093_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245877","volume":"15","author":"P. Christofi","year":"2023","unstructured":"Christofi, P., Pantazi, C., Psatha, N., Sakellari, I., Yannaki, E., and Papadopoulou, A. (2023) Promises and pitfalls of next-generation Treg adoptive immunotherapy, Cancers (Basel), 15, 5877, \nhttps:\/\/doi.org\/10.3390\/cancers15245877.","journal-title":"Cancers (Basel)"},{"key":"3093_CR44","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3727\/096368911X566217","volume":"20","author":"N. Marek","year":"2011","unstructured":"Marek, N., Bieniaszewska, M., Krzystyniak, A., Ju\u015bci\u0144ska, J., My\u015bliwska, J., Witkowski, P., Hellmann, A., and Trzonkowski, P. (2011) The time is crucial for ex vivo expansion of T regulatory cells for therapy, Cell Transplant., 20, 1747-1758, \nhttps:\/\/doi.org\/10.3727\/096368911X566217.","journal-title":"Cell Transplant."},{"key":"3093_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39636-x","volume":"9","author":"J. A. Gallaher","year":"2019","unstructured":"Gallaher, J. A., Brown, J. S., and Anderson, A. R. A. (2019) The impact of proliferation-migration tradeoffs on phenotypic evolution in cancer, Sci. Rep., 9, 2425, \nhttps:\/\/doi.org\/10.1038\/s41598-019-39636-x.","journal-title":"Sci. Rep."},{"key":"3093_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04053-5","volume":"7","author":"A. Zanin-Zhorov","year":"2017","unstructured":"Zanin-Zhorov, A., Kumari, S., Hippen, K. L., Merkel, S. C., MacMillan, M. L., Blazar, B. R., and Dustin, M. L. (2017) Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-\u03b8 restrained suppressive activity, Sci. Rep., 7, 4258, \nhttps:\/\/doi.org\/10.1038\/s41598-017-04053-5.","journal-title":"Sci. Rep."},{"key":"3093_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","volume":"37","author":"M. Kanamori","year":"2016","unstructured":"Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q., and Yoshimura, A. (2016) Induced regulatory T cells: their development, stability, and applications, Trends Immunol., 37, 803-811, \nhttps:\/\/doi.org\/10.1016\/j.it.2016.08.012.","journal-title":"Trends Immunol."},{"key":"3093_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110959","volume":"13","author":"V. G. Blinova","year":"2024","unstructured":"Blinova, V. G., and Zhdanov, D. D. (2024) Many faces of regulatory T cells: heterogeneity or plasticity? Cells, 13, 959, \nhttps:\/\/doi.org\/10.3390\/cells13110959.","journal-title":"Cells"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926601954","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:31:02Z","timestamp":1790951462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926601954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3093"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926601954","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All procedures involving donors were conducted in accordance with the 1964 Helsinki Declaration and its subsequent updates, as well as with the ethical standards of the Scientific Center of Neurology (Moscow). The study was approved by the Local Ethics Committee of the Scientific Center of Neurology (protocol no.\u00a012-3; December\u00a028, 2020). All donors provided written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}